Literature DB >> 10587337

Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea.

K Narkiewicz1, M Kato, B G Phillips, C A Pesek, D E Davison, V K Somers.   

Abstract

BACKGROUND: Patients with obstructive sleep apnea (OSA) have high levels of muscle sympathetic nerve activity (MSNA). We tested the hypothesis that long-term continuous positive airway pressure (CPAP) treatment will decrease MSNA in OSA patients. METHODS AND
RESULTS: We measured blood pressure, heart rate, and MSNA in 11 normotensive, otherwise healthy patients with OSA who were treated with CPAP. The measurements were obtained at baseline and after 1 month, 6 months, and 1 year of CPAP treatment. These measurements were compared with those recorded in 9 otherwise healthy OSA patients who were not treated with CPAP for 1 year. In both untreated and treated patients, blood pressure and heart rate did not change over time. MSNA was similar during repeated measurements in the untreated group. By contrast, MSNA decreased significantly over time in patients treated with CPAP. This decrease was evident after both 6 months and 1 year of CPAP treatment (P=0.02 for both).
CONCLUSIONS: CPAP treatment decreases muscle sympathetic traffic in patients with OSA. This effect of CPAP is evident only after an extended duration of therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10587337     DOI: 10.1161/01.cir.100.23.2332

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  118 in total

Review 1.  Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?

Authors:  D S Silverberg; A Oksenberg
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

3.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

Review 4.  Obstructive sleep apnea and hypertension.

Authors:  David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

5.  Improving Heart rate variability in sleep apnea patients: differences in treatment with auto-titrating positive airway pressure (APAP) versus conventional CPAP.

Authors:  Levent Karasulu; Pinar Ozkan Epöztürk; Sinem Nedime Sökücü; Levent Dalar; Sedat Altin
Journal:  Lung       Date:  2010-04-07       Impact factor: 2.584

Review 6.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

Review 7.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

8.  Follow-up assessment of CPAP efficacy in patients with obstructive sleep apnea using an ambulatory device based on peripheral arterial tonometry.

Authors:  Stephen D Pittman; Giora Pillar; Richard B Berry; Atul Malhotra; Mary M MacDonald; David P White
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

Review 9.  Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment.

Authors:  Corey J Leinum; John M Dopp; Barbara J Morgan
Journal:  Nutr Clin Pract       Date:  2009-12       Impact factor: 3.080

Review 10.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.